Azam Hosseinzadeh

Loop profile ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Topics

Oxidative Stress

Idiopathic Pulmonary Fibrosis

Top Venues

Fundamental & clinical pharmacology

Expert opinion on therapeutic targets

Diabetes/metabolism research and reviews

Drug and chemical toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Saeed Mehrzadi, Mohammad Sheibani, Fereshteh Koosha, Nazila Alinaghian, Mohammad Hossein Pourhanifeh, Seid Amir Pasha Tabaeian, Russel J Reiter, Azam Hosseinzadeh
Protective and therapeutic potential of melatonin against intestinal diseases: updated review of current data based on molecular mechanisms. Expert review of gastroenterology & hepatology (2023)
Farid Moradian, Mohammad Hossein Pourhanifeh, Saeed Mehrzadi, Arman Karimi-Behnagh, Azam Hosseinzadeh
Therapeutic potentials of melatonin in the treatment of lymphoma: A review of current evidence. Fundamental & clinical pharmacology 36 (5) (2022)
Saeed Mehrzadi, Mohammad Hossein Pourhanifeh, Alireza Mirzaei, Farid Moradian, Azam Hosseinzadeh
An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress. Cancer cell international 21 (1) (2021)
Mohammad Hossein Pourhanifeh, Mahboobeh Kamali, Saeed Mehrzadi, Azam Hosseinzadeh
Melatonin and neuroblastoma: a novel therapeutic approach. Molecular biology reports 48 (5) (2021)
Azam Hosseinzadeh, Mehdi Goudarzi, Iman Fatemi, Mohammad Javad Khodayar, Saeed Mehrzadi, Hamid Reza Khalili, Mohammad Ali Karimi
Gemfibrozil attenuates doxorubicin induced toxicity in renal tissues of male rats by reducing the oxidative insult and inflammation. Biotechnic & histochemistry : official publication of the Biological Stain Commission 95 (7) (2020)
Ehsan Dehdashtian, Mohammad Hossein Pourhanifeh, Karim Hemati, Saeed Mehrzadi, Azam Hosseinzadeh
Therapeutic application of nutraceuticals in diabetic nephropathy: Current evidence and future implications. Diabetes/metabolism research and reviews 36 (8) (2020)
Karim Hemati, Mohammad Hossein Pourhanifeh, Ehsan Dehdashtian, Iman Fatemi, Saeed Mehrzadi, Russel J Reiter, Azam Hosseinzadeh
Melatonin and morphine: potential beneficial effects of co-use. Fundamental & clinical pharmacology 35 (1) (2020)
Mohammad Hossein Pourhanifeh, Saeed Mehrzadi, Azam Hosseinzadeh
Melatonin and regulation of miRNAs: novel targeted therapy for cancerous and noncancerous disease. Epigenomics 13 (1) (2020)
Saeed Mehrzadi, Karim Hemati, Russel J Reiter, Azam Hosseinzadeh
Mitochondrial dysfunction in age-related macular degeneration: melatonin as a potential treatment. Expert opinion on therapeutic targets 24 (4) (2020)
Babak Gholamine, Gholamreza Houshmand, Azam Hosseinzadeh, Mojtaba Kalantar, Saeed Mehrzadi, Mehdi Goudarzi
Gallic acid ameliorates sodium arsenite-induced renal and hepatic toxicity in rats. Drug and chemical toxicology 44 (4) (2019)
Kobra Bahrampour Juybari, Azam Hosseinzadeh, Ali Mohammad Shariﬁ
Protective effects of atorvastatin against high glucose-induced nuclear factor-κB activation in cultured C28I2 chondrocytes. Journal of receptor and signal transduction research 39 (1) (2019)
Azam Hosseinzadeh, Seyed Ali Javad-Moosavi, Russel J Reiter, Rasoul Yarahmadi, Habib Ghaznavi, Saeed Mehrzadi
Oxidative/nitrosative stress, autophagy and apoptosis as therapeutic targets of melatonin in idiopathic pulmonary fibrosis. Expert opinion on therapeutic targets 22 (12) (2018)